Search

You searched for "stones"

519 results found

Prostate FFIT returns to Killie

20 January 2026
Free 12-week programme helps men affected by prostate cancer get stronger, fitter and feel more supported. Prostate Scotland and the SPFL Trust are offering 16 men affected by prostate cancer the chance to take part in a free 12-week health...

Lifestyle interventions for UI in women

1 March 2018 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology
Lifestyle interventions for urinary incontinence (UI) are supported by all major guidelines. The National Institute for Health and Care Excellence (NICE) guideline (CG171) from September 2013 (updated November 2015) [1] recommends lifestyle advice including dietary modifications such as caffeine reduction,...

Millions of women in their 40s are SUFFERING with bladder leakage

6 September 2019 | Research & Development
Two thirds of women over 40 are currently SUFFERING with bladder leakage – with many feeling EMBARRASSED and DEPRESSED as a direct result, a study found. The condition, which can be caused by childbirth and often develops as women get older, is believed to affect MILLIONS of females - of all ages.

Medical statistics for urologists: part 2 – probability and hypothesis testing

2 March 2022 |
Following on from Part 1 of this series (Part 3 available here), this article aims to build on other analytical techniques commonly used within medical research, focusing on simple examples. Probability and testing Before exploring hypothesis testing, it is vital...
European Urology journal front cover.

Defining adjuvant, consolidative, and salvage treatment after RP

2 July 2025 | | URO - Urologic Oncology
The most common oncologic outcome following radical prostatectomy (RP) for localised prostate cancer is achieving undetectable prostate-specific antigen (PSA) levels (<0.1 ng/ml), indicating an absence of detectable disease. However, the landscape of RP is shifting as active surveillance becomes the...

Innovative catheter receives “bacteria-phobic™” claim approval from notified body: positive evaluation affirms device resistance to bacterial colonisation

4 September 2019 | Research & Development
Camstent Ltd’s coated catheter, which has been developed to limit attachment of bacteria to its surfaces, a known source of Catheter Acquired Urinary Tract Infection (CAUTI), has been awarded approval...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...

‘One team’: our experience teaching catheter care and difficult urethral catheterisation to NHS Nightingale Hospital London volunteer staff members

4 September 2020 | | URO - Functional / Reconstructive Urology, URO - Technology
The NHS Nightingale Hospital London was launched in response to the COVID-19 pandemic. In mid-March 2020, the predicted scale of the pandemic was uncertain and there was concern that COVID-19 might overwhelm existing intensive care unit (ICU) capacity within weeks....

EBM Stats Calc: there’s a stat for that

1 November 2018 | | URO - Basic Science Research, URO - Technology
Quantifying the value of a specific test or intervention for a patient is no easy feat. Even when the value of a given test or intervention has been established, there may be additional case-specific factors to consider that are not...

IBSA UK&I assumes direct commercial responsibility for ialuril® in the UK and Ireland

9 April 2026 | Company Profiles, Contracts & Distributors
Transition supports continuity of supply and aligns ialuril® with IBSA’s expanding UK uro-gynaecology portfolio. Watford, UK – IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, today announces that it will assume direct responsibility for the commercialisation and distribution...

Management of RHC in prostate cancer with selective embolisation and hyperbaric oxygen therapy

4 July 2024 | | URO - Urologic Oncology
Prostate cancer is one of the most prevalent malignancies affecting men worldwide. Radiotherapy is a common treatment modality for localised and locally advanced prostate cancer. While radiotherapy can be effective, it may lead to complications such as radiation-induced haemorrhagic cystitis...

In conversation with Ian Pearce

21 August 2024 | URO - Core Urology
We were delighted to catch up with our old friend, Ian Pearce, former Editor of Urology News and new President of BAUS. Can you tell us a little bit about what led you into the field of urology and the...